Abstract
Comparative assessment of 111in-octreotide scintigraphy, 68GA-DOTATOC PET/CT and 18F-FDG PET/CT in the staging and management of neuroendocrine tumors (NETs)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have